期刊论文详细信息
Cardiovascular Diabetology | |
The risk of new-onset atrial fibrillation in patients with type 2 diabetes mellitus treated with sodium glucose cotransporter 2 inhibitors versus dipeptidyl peptidase-4 inhibitors | |
Chien-Ying Huang1  Cze-Ci Chan1  Ann Wan-Chin Ling1  Pao-Hsien Chu2  Yi-Hsin Chan3  Shao-Wei Chen4  Yi-Wei Kao5  | |
[1] Cardiovascular Department, Chang Gung Memorial Hospital, 33305, Linkou, Taoyuan, Taiwan;Cardiovascular Department, Chang Gung Memorial Hospital, 33305, Linkou, Taoyuan, Taiwan;College of Medicine, Chang Gung University, 33302, Taoyuan, Taiwan;Cardiovascular Department, Chang Gung Memorial Hospital, 33305, Linkou, Taoyuan, Taiwan;College of Medicine, Chang Gung University, 33302, Taoyuan, Taiwan;Microscopy Core Laboratory, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan;Division of Thoracic and Cardiovascular Surgery, Department of Surgery, Chang Gung Memorial Hospital, Linkou Medical Center, Chang Gung University, Taoyuan City, Taiwan;Center for Big Data Analytics and Statistics, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan;Graduate Institute of Business Administration, College of Management, Fu Jen Catholic University, Taipei, Taiwan; | |
关键词: Atrial fibrillation; Type 2 diabetes mellitus; Sodium glucose cotransporter-2 inhibitor; Dipeptidyl peptidase-4 inhibitor; Heart failure; | |
DOI : 10.1186/s12933-020-01162-w | |
来源: Springer | |